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1. Introduction
  Cardiac remodeling plays a vital role in the occurrence 
and development of many cardiovascular diseases like 
heart failure. It is also an independent risk factor that 
contributes to significantly increased morbidity and 
mortality of cardiovascular diseases. The occurrence of 
cardiac remodeling comprises of the change in myocardial 
cells and the remodeling of myocardial extracellular matrix 
(ECM). In addition, matrix metalloproteinases (MMP) serve 
as an important factor in the process of cardiac interstitium 
remodeling.
  Many researchers worldwide have demonstrated that, 
catecholamine that acts as neurotransmitters in sympathetic 
nerves may be one of the major stimulating factors for 
cardiac hypertrophy. Studies on clinical and animal 
genetics show that 毩1-AR plays an important role in the 
growth and development of myocardial cells, as well as its 
pathological cardiac hypertrophy[1]. However, there is still 
fewer studies on the inhibition of alpha receptor inhibitors 
on the remodeling of ECM. In our study, we observed the 
levels of MMP-2 and collagen栺 in myocardial cells in 
myocardia rat modelsinduced (NE) by norepinephrine, 
studied the effects on protein expressions by alpha 
receptor inhibitor phentolamine and explored the possible 
mechanisms. 
2. Materials and methods
2.1. Materials and establishment of animal model
  24 male SD rats were obtained from the Laboratory Animal 
Center of Nanjing Medical University with weight ranging 
from 240 to 280 g. These SD rats were randomly divided 
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into three groups: Group A, the normal control group (n=8); 
Group B, the NE group (n=8) with NE (purchased from 
Shanghai Hefeng Pharmaceutical Co., Ltd.) and Group C, the 
treatment group (n=8) with NE plus phentolamine (obtained 
from Shanghai Xudong Haipu Pharmaceutical Co., Ltd.). 
In the NE group, 8 male SD rats were intraperitoneally 
administrated with NE injection in a dose of 2.0 mg/kg.d, 
twice per day for continuously 15 days to establish the model 
of myocardial remodeling. SD rats in the control group were 
intraperitoneally injected with 0.9% saline. On the sixth day, 
SD rats were intraperitoneally injected with phentolamine in 
a dose of 5 mg/kg.d for 10 days after NE injection on the first 
day[2].  
2.2. Ultrasonic testing
  Each animal was anesthetized with an intraperitoneal 
injection of 3% pentobarbital sodium (50 mg/kg) before the 
execution. Philips iE33 Ultrasound Machine was used in 
our study, with sector array probe S8-3 (3-8 MHz). Probe 
was placed on the left chest and the level of the papillary 
muscles in the parasternal short axis view showed a 
satisfactory long axis parasternal two-dimensional image. 
The following parameters were determined including the left 
ventricular posterior wall thickness in the the systole (PWs) 
and diastole (PWd), the left ventricular end-systolic and 
end-diastolic diameter (LVEDs, LEVDd), interventricular 
septal thickness (IVS). The left ventricular ejection fraction 
(EF) and fraction shortening (FS) were calculated. Values of 3 
cardiac cycles were determined to obtain the mean value. 
2.3. Hearts weighing
  All animals were executed after all the examinations. 
Hearts were gathered quickly and the residual blood was 
wiped off with ice-cold saline to remove residual roots of 
great blood vessels and connective tissues. Whole heart 
weight (WHW) of each animal was recorded. The left 
ventricular weight (LVW) was determined after the atria 
and ventricle was removed and the left ventricular weight 
index (LVWI) was calculated as the following equation: 
LVWI=LVW/BW. Partial myocardial tissues from the left 
free ventricular wall were taken and were fixed in the 4% 
paraformaldehyde for histopathology examination and 
immunohistochemistry (IHC) staining. The remaining section 
were frozen and stored in liquid nitrogen. 
2.4. Hydroxyproline assay
  Hydroxyproline Assay Kit was from Nanjing JianCheng 
Bioengineering Institute. According to manufacturer’s 
instructions, hydroxyproline content in the left ventricular 
myocardial tissues was determined. Myocardial interstitial 
collagen contained 13.4% hydroxyproline in average and its 
content was expressed as the contents of hydroxyproline 
multiply 7.46. The unit 毺g/mg denoted the content of 
collagen (毺g) in tissues (mg).
2.5. Pathological examination 
2.5.1. Morphological observation of myocardial collagen and 
quantitative analysis 
  Paraffin-embedded myocardial tissue blocks were 
sectioned by a conventional microtome (about 4 毺m 
thick) and Van-Gieson (VG) method was used for staining 
(myocardial cells were yellow and collagen was red under 
microscope). Image-Pro 5.1 image analysis software was used 
to analyze the obtained images. Collagen volume fraction 
(CVF) was calculated as the following equation: CVF=the left 
ventricular collagen area/ field area determined. Six fields 
were selected randomly under microscope and their mean 
values were used as the cardiac CVF.  
2.5.2. MMP-2 and collagen 栺 protein expressions by IHC 
assay 
  The paraffin-embedded sections were routinely dewaxed 
to water and 3 mL/L hydrogen peroxide was added to 
inactivate endogenous peroxidase.  After heat induced 
antigen-retrieval methods, MMP-2 (1:200 dilution, Milipore) 
and collagen栺(1:200 dilution, Abcam) were added and 
incubated at 4 曟 overnight. Then, biotin-labeled secondary 
antibody was added and incubated at 37 曟 for 30 min. 
Thereafter, the horseradish peroxidase-labeled streptavidin 
working solution was added. The sections were developed 
with DAB and mounted. Image-Pro 5.1 image analysis 
software was used for images from MMP-2 (brown particles 
in the cytoplasm were expressed as positive) and collagen
栺protein (brown particles in cardiac interstitial collagen 
were expressed as positive). Five continuous high- power 
fields were selected in each section. In positive area, 5 fields 
were randomly selected to determine the average value 
of positive expression rates. The higher value calculated, 
the more positive expression quantity obtained. The semi-
quantitative analysis was conducted.  
2.6. Statistical analysis
  SPSS 17.0 software was used in our study. Quantitative data 
in all groups were expressed as mean依standard deviation 
(sd). ANOVA was used to compare the differences among the 
three groups when homogeneity of variance was observed. 
LSD was used to compare the differences between the three 
groups. P<0.05 were considered as statistical significant 
difference.
Yi-Gang Yin et al./Asian Pacific Journal of Tropical Medicine (2014)645-649 647
3. Results
3.1. Myocardial hypertrophy index
  As Table 1 below showed, there were no statistical 
differences in weights between three groups before and 
after administration. Compared with the control group, 
LHW and LVWI were significantly higher in the NE group 
(P<0.01). LHW and LVWI were significantly decreased in 
the treatment group, compared with the NE group (P<0.01), 
while those were significantly higher than the control group 
(P<0.05).
3.2. VG staining results
  In the control group, a small amount of fibrous tissues could 
be observed in the heart tissues. In the NE group, myocardial 
cells aligned disorderly, more collagen deposition could 
be observed around the small blood vessels in the cardiac 
muscles and total CVF was significantly increased in the 
left ventricular myocardium (P<0.01, Table 2). Myocardium 
collagen deposition in the treatment group was less than 
those of the NE group and CVF was significantly decreased 
(P<0.01); while there was no differences between the 
treatment group and the control group (P<0.05) (Table 2).
3.3. Collagen assay results
  Compared with the control group, hydroxyproline and 
collagen contents in the NE group were significantly 
increased (P<0.01). The collagen content in the treatment 
group was significantly lower than the NE group (P<0.01) and 
there was no statistical differences between the treatment 
group and the control group (P<0.01) (Table 2).
3.4. Ultrasonic cardiogram (UCG) results
  Compared with the control group, PWs, PWd and IVs were 
significantly higher (P<0.01) and LEVDd and EF significantly 
increased in the NE group (P<0.05). PWs, PWd and IVs in the 
treatment group were significantly lower than the NE group 
(P<0.01), while there was no statistical significant difference 
between the treatment group and the control group (P>0.05) 
(Table 3).
3.5. MMP-2 and collagen栺protein expressions in 
myocardium tissue
  MMP-2 was expressed in the myocardial cytoplasm and 
collagen 栺 protein was expressed in the extracellular 
matrix. Compared with the control group, expression levels 
of MMP-2 and collagen 栺 was significantly increased in the 
NE group (P<0.01) (Table 4, Figure1, 2). However, expression 
levels of MMP-2 and collagen 栺 of the treatment group was 
lower than those of the NE group, but higher than the control 
group (P<0.01) (Table 4, Figure 1, 2).
 
Figure 1. MMP-2 (×200) by IHC. 
Group A-the control group. Group B-the NE group. Group C- the 
treatment group. 
Table 1
HWI and CVF values of SD rats in all groups (n=8).
Groups Weight before administration (g) Weight after administration (g) LVW (mg) LVWI
Control group 257.63依10.80 295.70依12.02 628.03依48.15 2.12依0.14
NE group 261.35依10.63 273.73依13.59 772.13依63.01** 2.82依0.15**
Treatment group 263.30依13.37 287.27依18.43 685.63依26.79*## 2.39依0.13**##
**compared with the control group, P<0.01;  * compared with the control group, P<0.05, ## compared with the NE group, P<0.01.
Table 2
CVF% and hydroxyproline of SD rats in all groups (n=8).
Groups CVF% Hydroxyproline (毺g /mg) Collagen content (毺g /mg)
Control group 2.78依0.30 0.301依0.013 2.24依0.09
NE group 6.55依0.89** 0.502依0.026** 3.74依0.19**
Treatment group 4.13依0.77**## 0.417依0.019**## 3.11依0.09**##
** compared with the control group, P<0.01, ## compared with the NE group, P<0.01.
Table 3
Ventricular wall thickness and heart chambers by UCG of rats (n=8).
Groups PWd (mm) PWs (mm) IVs (mm) LVEDd (mm) LVEDs (mm) EF%
Control group 1.76依0.17 2.09依0.26 1.46依0.18 5.58依0.18 3.69依0.48 78.13依3.43
NE group 2.57依0.24** 2.96依0.13** 2.04依0.22** 5.30依0.14* 3.58依0.37 83.33依3.32*
Treatment group 1.93依0.14## 2.25依0.21## 1.51依0.15## 5.50依0.23 3.79依0.41 80.01依3.03
** compared with the control group, P<0.01, * compared with the control group, P<0.05,  ## compared with the NE group, P<0.01.
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Figure 2. Collagen 栺(×100). 
Group A-the control group. Group B-the NE group. Group C- the 
treatment group.
Table 4
MMP-2 and collagen 栺 (n=8).
Groups MMP-2 Collagen 栺
Control group 15.42依2.40 3.96依0.74
NE group 69.67依7.54** 20.38依1.46**
Treatment group 34.04依5.55**## 8.82依1.86**##
** compared with the control group, P<0.01, ## compared with the 
NE group, P<0.01.
4. Discussion
  Cardiac remodeling involves both the changes of 
myocardial cells and the rebuilding of cardiac interstitial 
network. ECM mainly comprises of type 栺 and 栿 collagen 
fibers, in which type 栺 collagen fiber accounts for 80 
percent of total myocardial collagen with strong stiffness 
and resistance to pull, while type III collagen fiber accounts 
for 11 percent with strong extensibility and elasticity. When 
cardiac remodeling occurs, the quantity of synthesized ECM 
increases, especially large amounts of type 栺 collagen 
fibers deposition lead to increased ventricular wall stiffness, 
decreased ventricular compliance and therefore progress to 
diastolic malfunction or even heart failure. MMPs are a large 
family of critical enzyme that degrades ECM and serves as an 
important factor in stabling ECM. It has been demonstrated 
that,  the increased level of MMPs expression directly 
degrade the matrix protein of ECM, the degradation products 
of which may serve as a stimulating factor of  collagen 
synthesis. Therefore, immature fiber tissues increase that 
lead to the increased collagen concentration in myocardial 
tissue and ECM remodeling[3-5]. Phentolamine is one of the 
alpha-receptor blocking agents that could partially blocks 
vasoconstriction due to the increased sympathetic activity, 
dilates arteries and veins of the whole body and decreases 
cardiac preload and afterload. However, there are still few 
studies on the effect of ECM remodeling by phentolamine 
and prior studies gained controversial conclusions.
  In our study, we successfully established rats model of 
cardiac hypertrophy by NE induction, which could be 
demonstrated by obviously increased levels of PWs, PWd, 
IVs, LVEDd and EF in UCGs, compared with those of the 
control group, as well as significantly increased values of 
rats LHW and LVWI compared to the control group. In the 
NE group, markedly increased contents of total collagen 
(VG staining) and hydroxyproline in the myocardial tissues 
confirm that, NE stimulation lead to the occurrence of rats 
cardiac remodeling and fibrosis[6-8] and expression levels 
of MMP-2 and collagen栺 in the NE group were apparently 
higher than those of the control group. After interventions of 
rats myocardial remodeling by phentolamine, UCGs, LVWI, 
CVF%, contents of hydroxyproline, MMP-2 and collagen 
栺 expression levels were obviously lower than those of NE 
group, but still higher than the control group, therefore it 
can be interpreted that phentolamine may partially block 
myocardial hypertrophy and fibrosis induced by NE. The 
inhibition of phentolamine on ECG remodeling due to the 
expression levels of MMP-2 decreased and contents of 
collagen 栺 and collagen reduced. It is speculated that, 
one of the possible mechanisms may be that among the 
myocardial cells released cytokines including TNF-毩, 
interlukin-1 and intelukin-6[9-11], TNF-毩 could activate 
the expressions of c-jun gene, thus activate metalloprotease 
gene expression and increased MMP expression and 
activation observed[12,13] which directly lead to myocardial 
collagen content increased[14-17]. MMP-2 plays an important 
role in cardiac hypertrophy , left ventricle dilation and 
heart failure, which has the potential to degrade both gelatin 
and collagen in the cardiac interstitium[18-20]. Our study 
shows, phentolamine may block sympathetic nerve activity, 
myocardial cells released TNF-毩 and inflammatory factors 
reduced, therefore expression levels of MMP-2 reduced and 
ECG remodeling improved.
  It is believed that, NE mediates cardiac hypertrophy 
mainly through alpha receptor, but beta receptor also play 
an important part in the process[21-24]. Zhangheng proposed 
that[25] either alpha 1-AR blocking agent prozosin or beta-
AR blocking agent propranolol could partially block the 
induced myocardial hypertrophy by NE, or block the induced 
myocardial hypertrophy completely. Our research indicates 
that phentolamine could effectively alleviate myocardial 
hypertrophy and ECG remodeling induced by NE. Therefore, 
it can be speculated that, the combination of alpha 1 and 
beta receptor blockers could improve cardiac remodeling 
due to the activation of chronic sympathetic nervous system 
at the early stage of some cardiovascular diseases with  high 
sympathetic nerve activity (e.g., coronary heart disease, 
hypertensive heart disease, heart failure). Furthermore, it 
provides theoretical basis for slowing down the pathological 
process of heart failure. However, more studies are needed 
to explore and verify the specific mechanism. 
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